FDA clears Medison’s SA 8800

Article

Medison America received clearance Aug. 21 for the company's SonoAce 8800 scanner, according to M.T. Kwon, president and CEO of the Pleasanton, CA, company. A collaborative effort between Medison and development partner ATL Ultrasound of Bothell, WA, SA

Medison America received clearance Aug. 21 for the company's SonoAce 8800 scanner, according to M.T. Kwon, president and CEO of the Pleasanton, CA, company. A collaborative effort between Medison and development partner ATL Ultrasound of Bothell, WA, SA 8800 is a mid-range color Doppler scanner that carries a 64-channel digital beamformer. As an added bonus, the scanner also supports 3-D imaging and can produce qualitative 3-D images in multiple planes or volumes.

ATL will sell the unit as HDI 1500 and expects to list it between $70,000 and $100,000. Medison and ATL entered into partnership earlier this year to develop and distribute mid-range digital ultrasound scanners (SCAN 5/13/98), and HDI 1500 evolved from the cooperative efforts of the two companies.

In other Medison news, the company has received 510(k) clearance for a power Doppler mode for Combison 530D, the firm's integrated 3-D ultrasound scanner.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.